Contact
Please use this form to send email to PR contact of this press release:
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
TO:
Please use this form to send email to PR contact of this press release:
Rationale for FDA’s Position on the Cefazolin Breakpoints for Enterobacterales
TO: